9 unchanged sentences
8-K 000-53290 3.1 3/19/2025
−Removed: 3.4 Amended and Restated Bylaws of Niagen Bioscience, Inc.
+Added: 3.4 Amended and Restated By laws of Niagen Bioscience, Inc.
8-K 000-53290 3.1 3/19/2025
1 unchanged sentence
10-Q 001-37752 4.1 5/7/2025
−Removed: Niagen Bioscience, Inc.
−Removed: 2017 Equity Incentive Plan, as amended +
−Removed: 8-K 001-37752 10.1 6/27/2025
−Removed: Niagen Bioscience, Inc.
−Removed: Employee Stock Purchase Plan +
−Removed: 8-K 001-37752 10.2 6/27/2025
10.1 Sales Agreement, dated July 25, 2025, by and between ChromaDex, Inc.
Grace & Co.-Conn .
−Removed: 8-K 001-37752 10.1 7/29/2025
+Added: 10.1 7/29/2025
Certification of the Chief Executive Officer pursuant to Rule 13a-14(A) of the Securities Exchange Act of 1934, as amended
10 unchanged sentences
* Certain portions of this exhibit are omitted because they are both not material and are the type that the Registrant treats as private or confidential.
−Removed: + Indicates management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
NIAGEN BIOSCIENCE, INC.
−Removed: August 6, 2025 /s/ OZAN PAMIR
+Added: November 4, 2025 /s/ OZAN PAMIR
Chief Financial Officer
1 unchanged sentence
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.